The EBCTCG overview of adjuvant therapy of breast cancer. What are the implications for future studies? Early Breast Cancer Trialists' Collaborative Group.

The EBCTCG overview of adjuvant therapy of breast cancer. What are the implications for future studies? Early Breast Cancer Trialists' Collaborative Group.

Detalles Bibliográficos
Main Authors:	Gray, R, Clarke, M, Collins, R, Peto, R
Formato:	Conference item
Publicado:	1993

Títulos similares

THE EBCTCG OVERVIEW OF ADJUVANT THERAPY OF BREAST-CANCER
por: Gray, R, et al.
Publicado: (1994)

EARLY BREAST-CANCER TRIALISTS COLLABORATION
por: Peto, R
Publicado: (1987)

Meta-analyses of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists' Collaborative Group overview.
por: Clarke, M
Publicado: (2006)

Worldwide meta-analyses of breast cancer treatment - EBCTCG 2005 - an update
por: Peto, R
Publicado: (2005)

The EBCTCG Oxford Overview, 1984-2012
por: Peto, R
Publicado: (2012)

Which adjuvant endocrine therapy for ER-positive non-metastatic breast cancer? EBCTCG-2000 update: Tamoxifen, castration, LHRH-agonists
por: Davies, C, et al.
Publicado: (2002)

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
por: Collins, R, et al.
Publicado: (1994)

Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer.
por: Cuzick, J, et al.
Publicado: (1987)

Early breast cancer - the randomised evidence
por: Peto, R, et al.
Publicado: (1999)

Update of the worldwide evidence on the adjuvant treatment of breast cancer
por: Peto, R, et al.
Publicado: (2002)

Radiotherapy and surgery in early breast cancer - Reply
por: Peto, R, et al.
Publicado: (1996)

Facts and figures from the meta-analyses in breast cancer
por: Peto, R, et al.
Publicado: (1998)

EFFECTS OF ADJUVANT TAMOXIFEN AND OF CYTOTOXIC THERAPY ON MORTALITY IN EARLY BREAST-CANCER - AN OVERVIEW OF 61 RANDOMIZED TRIALS AMONG 28,896 WOMEN
por: Peto, R
Publicado: (1989)

Inferring the effects of cancer treatment: divergent results from early breast cancer trialists' collaborative group meta-analyses of randomized trials and observational data from SEER registries
por: Henson, K, et al.
Publicado: (2016)

PROS AND CONS OF OVERVIEWS OF RANDOMIZED TRIALS IN BREAST-CANCER AND VASCULAR-DISEASE
por: Peto, R
Publicado: (1986)

Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST)
por: Maria Luisa Gasparri, et al.
Publicado: (2020-08-01)

Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials
por: Gray, R, et al.
Publicado: (2001)

What is the risk of cardiac morbidity with adjuvant radiotherapy for breast cancer?
por: Vallis, K
Publicado: (2006)

Overview of Breast Cancer and Implications of Overtreatment of Early-Stage Breast Cancer: An Indian Perspective
por: Gouri Shankar Bhattacharyya, et al.
Publicado: (2020-11-01)

Management of breast cancer.
por: Peto, R
Publicado: (1992)

Phase i trialist
por: Scott, J
Publicado: (2012)

Adjuvant treatment for breast cancer
por: Flatley, M, et al.
Publicado: (2019)

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals The ARB Trialists Collaboration
por: Teo, K, et al.
Publicado: (2011)

RAUWOLFIA DERIVATIVES AND BREAST-CANCER
por: Peto, R
Publicado: (1974)

Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
por: Black, H, et al.
Publicado: (1998)

Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries.
por: Beral, V, et al.
Publicado: (2004)

Tamoxifen therapy for patients with breast cancer - Authors' reply.
por: Davies, C, et al.
Publicado: (2013)

PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER
por: R. I. Yagudina, et al.
Publicado: (2015-03-01)

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.
por: Appleby, P, et al.
Publicado: (1994)

The Blood Pressure Lowering Treatment Trialists’ Collaboration: methodological clarifications of recent reports
por: Nazarzadeh, M, et al.
Publicado: (2022)

Review: Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy?
por: Michael Gnant, et al.
Publicado: (2009-11-01)

Adjuvant therapy for early breast cancer
por: I. V. Vysotskaya
Publicado: (2014-07-01)

Metformin as an adjuvant in breast cancer treatment
por: Mohsin HK Roshan, et al.
Publicado: (2019-07-01)

CYTO-TOXIC CHEMOTHERAPY IN BREAST-CANCER
por: Peto, R
Publicado: (1985)

Birthweight as risk factor for breast cancer.
por: Peto, R
Publicado: (1997)

CYTO-TOXIC CHEMOTHERAPY IN BREAST-CANCER - REPLY
por: Peto, R
Publicado: (1985)

The 2006 worldwide overview of the effects of local treatments for early breast cancer on long-term outcome
por: McGale, P, et al.
Publicado: (2006)

The 2006 worldwide overview of the effects of local treatments for early breast cancer on long-term outcome
por: Darby, S, et al.
Publicado: (2006)

Interpretation of operative risks of individual surgeons. European Carotid Surgery Trialists' Collaborative Group.
por: Rothwell, P, et al.
Publicado: (1999)

Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. HIV Trialists' Collaborative Group.
por: Abrams, D, et al.
Publicado: (1999)